<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sean Mackey | Eric Cramer</title>
    <link>http://emcramer.github.io/authors/sean-mackey/</link>
      <atom:link href="http://emcramer.github.io/authors/sean-mackey/index.xml" rel="self" type="application/rss+xml" />
    <description>Sean Mackey</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>© `2021`</copyright><lastBuildDate>Sun, 24 Jan 2021 17:01:15 -0800</lastBuildDate>
    <image>
      <url>http://emcramer.github.io/images/icon_hud9b055eee01d4de0eb2efdace9b98bee_9571_512x512_fill_lanczos_center_2.png</url>
      <title>Sean Mackey</title>
      <link>http://emcramer.github.io/authors/sean-mackey/</link>
    </image>
    
    <item>
      <title>The association of the Stanford Expectations of Treatment Scale (SETS) with expectations on pain and opioid dose in a patient-centered prescription opioid tapering program</title>
      <link>http://emcramer.github.io/talk/aapm2021/</link>
      <pubDate>Sun, 24 Jan 2021 17:01:15 -0800</pubDate>
      <guid>http://emcramer.github.io/talk/aapm2021/</guid>
      <description>&lt;p&gt;The Stanford Expectations of Treatment Scale (SETS) is a tool developed to measure patient outcome expectancy prior to treatment. It has been validated in patients receiving surgical and pain interventions, but its relationship with expectancies regarding opioid use tapering has not previously been examined. We aim to characterize the relationship between the SETS scores and patient expectancy regarding opioid tapering and pain levels post tapering.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Development and validation of the Collaborative Health Outcomes Information Registry body map</title>
      <link>http://emcramer.github.io/publication/scherrer-2021/</link>
      <pubDate>Sun, 24 Jan 2021 16:44:05 -0800</pubDate>
      <guid>http://emcramer.github.io/publication/scherrer-2021/</guid>
      <description>&lt;script type=&#34;text/javascript&#34; src=&#34;https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js&#34;&gt;&lt;/script&gt;&lt;div class=&#34;altmetric-embed&#34; data-badge-type=&#34;donut&#34; data-altmetric-id=&#34;98609954&#34; /&gt;
&lt;p&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; 
Critical for the diagnosis and treatment of chronic pain is the anatomical distribution of pain. Several body maps allow patients to indicate pain areas on paper; however, each has its limitations.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Objectives:&lt;/strong&gt; 
To provide a comprehensive body map that can be universally applied across pain conditions, we developed the electronic Collaborative Health Outcomes Information Registry (CHOIR) self-report body map by performing an environmental scan and assessing existing body maps.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods:&lt;/strong&gt; 
After initial validation using a Delphi technique, we compared (1) pain location questionnaire responses of 530 participants with chronic pain with (2) their pain endorsements on the CHOIR body map (CBM) graphic. A subset of participants (n = 278) repeated the survey 1 week later to assess test–retest reliability. Finally, we interviewed a patient cohort from a tertiary pain management clinic (n = 28) to identify reasons for endorsement discordances.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results:&lt;/strong&gt; 
The intraclass correlation coefficient between the total number of body areas endorsed on the survey and those from the body map was 0.86 and improved to 0.93 at follow-up. The intraclass correlation coefficient of the 2 body map graphics separated by 1 week was 0.93. Further examination demonstrated high consistency between the questionnaire and CBM graphic (&amp;lt;10% discordance) in most body areas except for the back and shoulders (≈15–19% discordance). Participants attributed inconsistencies to misinterpretation of body regions and laterality, the latter of which was addressed by modifying the instructions.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; 
Our data suggest that the CBM is a valid and reliable instrument for assessing the distribution of pain.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
